NAPOLI-3: A randomized, open-label Phase 3 study of liposomal irinotecan+5-fluorouracil/leucovorin plus oxaliplatin (NALIRIFOX) versus nab-paclitaxel plus gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (mPDAC)

被引：0

作者：

Goetze, T. ^{[1
]}

Melisi, D. ^{[2
]}

Macarulla, T. ^{[3
]}

Pazo Cid, A. R. ^{[4
]}

Chandana, R. S. ^{[5
]}

De La Fouchardiere, C. ^{[6
]}

Dean, A. ^{[7
]}

Kiss, I. ^{[8
,9
]}

Lee, Jin W. ^{[10
]}

Van Cutsem, E. ^{[11
,12
]}

Paulson, S. ^{[13
]}

Bekaii-Saab, T. ^{[14
]}

Pant, S. ^{[15
]}

Hubner, R. ^{[16
]}

Xiao, Z. ^{[17
]}

Chen, H. ^{[17
]}

Benzaghou, F. ^{[17
]}

O'Reilly, E. ^{[18
]}

Wainberg, A. Z. ^{[19
]}

机构：

[1] Krankenhaus NW Frankfurt, Frankfurt, Germany

[2] Azienda Osped Univ Integrata, Invest Canc Therapeut Clin Unit, Verona, Italy

[3] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol VHIO, Barcelona, Spain

[4] Hosp Univ Miguel Servet, Zaragoza, Spain

[5] Canc & Hematol Ctr Western Michigan, Grand Rapids, MI USA

[6] Ctr Leon Berard, Lyon, France

[7] St John God Subiaco Hosp, Subiaco, WA, Australia

[8] Masaryk Mem Canc Inst, Brno, Czech Republic

[9] Fac Med, Brno, Czech Republic

[10] Natl Canc Ctr, Govang, South Korea

[11] Univ Hosp Gasthuisberg, Leuven, Belgium

[12] KULeuven, Leuven, Belgium

[13] Texas Oncol Baylor Charles A Sammons Canc Ctr, Dallas, TX USA

[14] Mayo Clin, Scottsdale, AZ USA

[15] MD Anderson Canc Ctr, Houston, TX USA

[16] Christie NHS Fdn Trust, Manchester, Lancs, England

[17] Ipsen, Cambridge, England

[18] Mem Sloan Kettering Canc Ctr, New York, NY USA

[19] Univ Calif Los Angeles, Los Angeles, CA USA

来源：

ONCOLOGY RESEARCH AND TREATMENT | 2023年 / 46卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

V54

引用

页码：12 / 14

页数：2